Cargando…
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
The advent of immunotherapy has marked a new era in cancer treatment, offering significant clinical benefits. Cell membrane as drug delivery materials has played a crucial role in enhancing cancer therapy because of their inherent biocompatibility and negligible immunogenicity. Different cell membra...
Autores principales: | Cheng, Qinzhen, Kang, Yong, Yao, Bin, Dong, Jinrui, Zhu, Yalan, He, Yiling, Ji, Xiaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502869/ https://www.ncbi.nlm.nih.gov/pubmed/37409429 http://dx.doi.org/10.1002/advs.202302131 |
Ejemplares similares
-
Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis
por: Yu, Yongkang, et al.
Publicado: (2022) -
Engineering high‐affinity dual targeting cellular nanovesicles for optimised cancer immunotherapy
por: Zhang, Luyao, et al.
Publicado: (2023) -
Size-transformable antigen-presenting cell–mimicking nanovesicles potentiate effective cancer immunotherapy
por: Yang, Weijing, et al.
Publicado: (2020) -
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
por: Tong, Qing, et al.
Publicado: (2023) -
Phospholipid-Membrane-Based Nanovesicles Acting as Vaccines for Tumor Immunotherapy: Classification, Mechanisms and Applications
por: Chen, Wenjuan, et al.
Publicado: (2022)